"Sema4 Launches New Genomic Testing and Digital Tools for Use in Oncology"
Sema4, a patient-centered health intelligence company, today announced the launch of several new genomic testing services and digital tools to help oncologists deliver on the promise of precision medicine. Together, these products provide a comprehensive approach that can be used throughout a patient’s journey, from assessing risk to analyzing cancer and monitoring in remission. “Working with a large healthcare system and as a practicing oncologist myself, the most important thing is getting this molecular data and the informatics in a timetable that allows me to continue to take care of my patients,” said William Oh, MD, professor of medicine, hematology, urology, and medical oncology at the Icahn School of Medicine at Mount Sinai. According to Andrew Kaufman, MD, associate professor of thoracic surgery at the Icahn School of Medicine at Mount Sinai, “In healthcare, like any other industry, we’re really looking for efficiency in connecting the dots of so much data. Sema4 has come up with a novel way to look at patient data that is extremely powerful.” Elisa Port, MD, FACS, director of the Dubin Breast Center and chief of breast surgery at The Mount Sinai Health System, also stated, “Sema4 is going to have a very widespread impact on the patients we treat here because the company’s tests open up the opportunity for genetic testing across a much broader base of patients and streamline and expedite the process.
— William K. Oh, MD, Professor, Medicine, Hematology, Medical Oncology, Urology, Associate Director, Clinical Research, Tisch Cancer Institute, Chief, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai
— Andrew J. Kaufman, MD, Associate Professor, Thoracic Surgery, Associate Program Director, Surgery Residency Program, Icahn School of Medicine at Mount Sinai, Director, Thoracic Surgery Airway Program, Asian Thoracic Surgery Program, Mount Sinai Health System
— Elisa R. Port, MD, FACS, Associate Professor, Surgery, Icahn School of Medicine at Mount Sinai, Director, Dubin Breast Center, Chief, Breast Surgery, The Mount Sinai Hospital
Additional coverage: Fox 34;First World Med Tech
Future Breast Imaging and Biopsy Are Not Eliminated After Mastectomy
Oct 09, 2018 View All Press Releases